- Case report
- Open Access
- Open Peer Review
Primary melanoma of the small bowel revealed by gastrointestinal bleeding: a case report
© The Author(s). 2016
- Received: 27 August 2016
- Accepted: 24 October 2016
- Published: 1 December 2016
Primary melanoma of the small bowel is extremely rare. Only a limited number of cases have been described in the literature. Mostly, the small intestine is affected by metastatic tumors of other primary lesions, especially cutaneous.
We report the case of a 75-year-old North African woman with a small bowel melanoma. The diagnosis was made by histological examination and immunohistochemical profile matching after a segmental small bowel resection. Postoperative investigations looking for cutaneous, gastrointestinal or ocular primary lesions found no abnormalities.
The diagnosis of primary small bowel melanoma can be retained although it remains difficult to exclude the possibility of metastatic melanoma.
- Intestinal melanoma
- Primary melanoma of the small bowel
- Gastrointestinal bleeding
Melanoma is a malignant tumor developed from melanocytes which are usually located in the skin, the eye’s choroid, the meninges, and the anal margin. Melanoma of the gastrointestinal tract represent 1 to 3% of the digestive cancers [1, 2], it is essentially a metastasis of a cutaneous, ocular, or anal primary lesion . Primary melanoma of the small bowel is exceptional, only few cases have been reported in the literature due to the difficulty in excluding another primary cancer [2, 4]. Regardless of its primary or secondary character, intestinal melanoma remains more aggressive with a poor prognosis compared to other nondigestive locations. The median overall survival is 4 to 6 months with a survival rate of less than 10% at 5 years [3, 5].
With regard to therapeutic approach, there is no real consensus in the curative treatment of primary melanoma of the gastrointestinal tract. Surgery remains an essential approach for this disease, since effective adjuvant systemic therapies are without benefit for overall survival . The optimal surgical technique consists of a carcinologic resection of the tumor.
Melanoma develops in the melanocytes, which are dendritic cells present in the skin, the eye, and the epithelium of the nasal cavity, oropharynx, anus, vagina, and urinary tract. In addition to these sites, it was proven by immunoperoxidase studies that melanocytes are present in Meckel’s diverticulum [7, 8]. Normally, the small intestine and the colon do not contain melanocytes. Embryologically, they arise from neural crest melanoblasts which migrate to the distal ileum through the umbilical-mesenteric canal [7, 9]. They differentiate by amine precursor uptake and decarboxylation (APUD), and can undergo neoplastic transformation in noncutaneous sites . According to this theory, the ileum is the most common site for the development of primary melanoma of the small intestine, although some authors still deny the existence of primary melanoma in the gastrointestinal tract. They argue that primary cutaneous tumors can regress before metastatic manifestations or they are too small to be identified by clinical and laboratory examinations . Primary or secondary gastrointestinal melanoma is difficult to establish resulting in many controversies .The gastrointestinal tract is the most common site of cutaneous melanoma metastasis [4, 10]. Usually asymptomatic, metastases are diagnosed at autopsy in 58% of patients with cutaneous melanoma , they may be clinically detected only after treatment of primary melanoma, or spontaneous regression , affecting primarily the small intestine, stomach, and colon [4, 12]. However, some gastrointestinal melanomas remain undocumented and without evidence of a primary lesion, cutaneous or elsewhere, even after a thorough examination .The incidence of metastatic gastrointestinal melanoma of unknown primary origin is from 4 to 9% in case series . In order to distinguish between primary and metastatic intestinal melanoma, Bender et al. were able to identify four different types of metastatic melanoma of the small intestine based solely on histopathological features: cavitary, infiltrating, eccentric, and polypoid . Lymphocytic infiltrate with melanophages, restorative fibrosis, and a vascular proliferation present in the dermis are commonly seen in intestinal metastatic melanoma developed after spontaneous regression of the primary cutaneous lesion . To make the diagnosis of primary malignant melanoma of the small intestine, other authors recommend excluding any history of melanoma in the other major sites. Sacks et al. established three diagnostic criteria: (1) single lesion, (2) no metastatic location other than in the regional lymph nodes, (3) relapse-free survival of more than 1 year after diagnosis .
In our case, histological study confirmed the diagnosis of intestinal melanoma with concordant immunohistochemical profile; our patient had no history of cutaneous melanoma, and etiological examination found no other melanoma lesion. At 1-year follow-up, clinical examination and abdominal CT scan control showed no intraperitoneal signs of recurrence. The diagnosis of a primary malignant melanoma of the small bowel has been established.
Adjuvant systemic therapy has a limited role, different chemotherapy regimens have been applied but the response rates were extremely low . In our case, no adjuvant therapy was administered.
The diagnosis of primary intestinal melanoma can be confirmed based on the criteria described in the literature; however, early diagnosis and surgical resection are essential for improving the prognosis.
No funding involved.
Availability of data and materials
AB drafted and edited the manuscript. RA contributed to the writing of the manuscript. AJ drafted the pathology section. CB critically revised the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this manuscript and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Elsayed AM, Albahra M, Nzeako UC, Sobin LH. Malignant melanomas in the small intestine: a study of 103 patients. Am J Gastroenterol. 1996;91(5):1001–6.PubMedGoogle Scholar
- Atmatzidis KS, Pavlidis TE, Papaziogas BT, Papaziogas TB. Primary malignant melanoma of the small intestine: report of a case. Surg Today. 2002;32:831–3.View ArticlePubMedGoogle Scholar
- Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664–78.View ArticlePubMedGoogle Scholar
- Kadivar TF, Vanek VW, Krishnan EU. Primary malignant melanoma of the small bowel: a case study. Am Surg. 1992;58(7):418–22.PubMedGoogle Scholar
- Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol. 2000;12:181–5.View ArticlePubMedGoogle Scholar
- Lens M, Bataille V, Krivokapic Z. Melanoma of the small intestine. Lancet. 2009;10:516–21.View ArticlePubMedGoogle Scholar
- Amar A, Jougon J, Edouard A, Laban P, Marry JP, Hillion G. Primary malignant melanoma of the small intestine. Gastroenterol Clin Biol. 1991;16(4):365–7.Google Scholar
- Bloch T, Tejada E, Brodhecker C. Malignant melanoma in Meckel’s diverticulum. Am J Clin Pathol. 1986;86:231–4.View ArticlePubMedGoogle Scholar
- DasGupta TK, Brasfield RD. Metastatic melanoma of the gastrointestinal tract. Arch Surg. 1964;88:969–73.View ArticlePubMedGoogle Scholar
- Krüger S, Noack F, Blöchle C, Feller AC. Primary malignant melanoma of the small bowel: a case report and review of the literature. Tumori. 2004;91(1):73–6.Google Scholar
- Poggi SH, Madison JF, Hwu WJ, Bayar S, Salem RR. Colonic melanoma, primary or regressed primary. J Clin Gastroenterol. 2000;30:441–4.View ArticlePubMedGoogle Scholar
- Avital S, Romaguera RL, Sands L, Marchetti F, Hellinger MD. Primary malignant melanoma of the right colon. Am Surg. 2004;70(7):649–51.PubMedGoogle Scholar
- Woollons A, Derrick EK, Price ML, Darley CR. Gastrointestinal malignant melanoma. Int J Dermatol. 1997;36:129–31.View ArticlePubMedGoogle Scholar
- Manouras A, Genetzakis M, Lagoudianakis E, et al. Malignant gastrointestinal melanomas of unknown origin: should it be considered primary? World J Gastroenterol. 2007;13:4027–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Bender GN, Maglinte DD, McLarney JH, Rex D, Kelvin FM. Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance. Am J Gastroenterol. 2001;96(8):2392–400.PubMedGoogle Scholar
- Sachs DL, Lowe L, Chang AE, et al. Do primary small intestinal melanomas exist? Report of a case. J Am Acad Dermatol. 1999;41:1042–4.View ArticlePubMedGoogle Scholar